Aug 2026· Nanomedicine· Vol 21, pp.
1-20
· 0 citations· 19 references
Medicine
TL;DR
LRP-1-targeted LRP-1-targeted Lf-LNT-PEG-CS-NCs significantly enhanced intranasal brain delivery, cellular uptake, and apoptotic activity of LNT, demonstrating a promising noninvasive platform for targeted GBM therapy.
Abstract
Aim
To develop and evaluate a lactoferrin (Lf)-functionalized polyethylene glycol (PEG)-grafted chitosan (CS) nanocarriers (NCs) for low-density lipoprotein receptor-related protein-1 (LRP1)-mediated intranasal delivery of lentinan (LNT) to enhance brain targeting and anti-glioblastoma (GBM) efficacy.
Materials And Methods
Lf-LNT-PEG-CS-NCs were prepared, optimized, and characterized for particle size, entrapment efficiency, coating efficiency, and release behavior. Ex vivo permeation, cellular uptake, cytotoxicity, apoptosis, pharmacokinetic, and biodistribution studies were performed using U87 MG cells and Wistar rats.
Results
The optimized NCs exhibited a particle size of 205.3 ± 11 nm, entrapment efficiency of 71.52 ± 0.98%, and coating efficiency of 92.42 ± 0.94%, with sustained drug release for 36 h. The permeation increased by 2.86-fold, while cellular uptake reached 78.38 ± 3.76%. Treatment significantly reduced U87 MG cell viability (84.21 ± 2.75% inhibition) and induced apoptosis with 64.55 ± 2.28% G0/G1 arrest, accompanied by reduced COX-2 (55.81 ± 2.91%) and Bcl-2 (59.65 ± 1.95%) expression and increased caspase-3 (73.10 ± 2.91%). Intranasal administration achieved a CSF Cmax of 46.72 ± 3.78 μg/mL and brain accumulation of 42.83 ± 2.59 μg/mL.
Conclusion
LRP-1-targeted Lf-LNT-PEG-CS-NCs significantly enhanced intranasal brain delivery, cellular uptake, and apoptotic activity of LNT, demonstrating a promising noninvasive platform for targeted GBM therapy.
Glioblastoma (GBM) remains a highly aggressive brain malignancy with limited therapeutic success owing to poor drug accumulation and restricted brain delivery. Dasatinib (DTB), a tyrosine kinase inhibitor with anticancer potential, is limited by poor solubility and brain penetration. This study developed l-arginine-gra...
Mansi Thakur, Aditi Sonone, Sagar S. Trivedi et al.· Nanomedicine: Nanotechnology...· 0 citations
The molecular complexity and adaptive resistance of melanoma limit the efficacy of conventional monotherapies, driving the development of multimodal therapeutic strategies. Here, we report the design and characterization of solid lipid-polymer hybrid nanoparticles (SLPHs) incorporating a FITC-labeled cationic polymer a...
Y. G. Gonçalves, Breno H. Martinez, L. O. Sousa et al.· Colloids and Surfaces B: Bio...· 0 citations
Gastric cancer (GC) has a poor prognosis. Chemotherapy causes severe systemic toxicity, and only a small subset of patients benefits from HER2/PD‑L1‑targeted therapies. Tricin (TRI), a natural flavonoid with anti‑GC activity, is limited by poor water solubility and low bioavailability. This study aimed to construct TRI...
Bai-Ji Cui, Hong-Mei Zhang, Hao Wu et al.· Chemistry and Biodiversity· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to chemotherapy due to dense stromal barriers. Although gemcitabine remains the standard treatment, its efficacy is limited. Combining it with the pseudopeptide N6L has shown synergistic effects, but administering them individually in biological systems poses...
L. Larue, Blandine Brissault, Cléa Chesneau et al.· Biomacromolecules· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.